<?xml version="1.0"?>
<npl:medprod xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mpa="urn:schemas-npl:mpa:12" xsi:schemaLocation="urn:schemas-npl:instance:12 ../schemas/npl-schema_12.0.xsd" xmlns:npl="urn:schemas-npl:instance:12">
  <mpa:nplid>20140201000103</mpa:nplid>
  <npl:names>
    <mpa:medprodname v="Fasinex 240 mg/ml" />
    <mpa:medprodnamelegal v="Fasinex 240 mg/ml" />
  </npl:names>
  <mpa:strength-text>
    <mpa:v>240 mg/ml</mpa:v>
  </mpa:strength-text>
  <mpa:pharmaceutical-form-lx v="ORASUS" lexicon="pharmaceutical-form-lx" />
  <npl:organizations>
    <mpa:organization>
      <mpa:organization-lx v="ID1Y64H93RTDLDHMSR" />
      <mpa:organization-role-lx v="MAH" lexicon="organization-role-lx" />
    </mpa:organization>
  </npl:organizations>
  <mpa:productclass-lx v="LIC" lexicon="productclass-lx" />
  <mpa:prescription-lx v="1" lexicon="prescription-lx" />
  <npl:classifications>
    <mpa:atc-code-lx v="QP52AC01" />
    <mpa:controlled-medicinal-product-lx v="N" lexicon="yesno-lx" />
    <mpa:narcotic-class-lx v="0" lexicon="narcotic-classification-lx" />
  </npl:classifications>
  <npl:flags>
    <mpa:salesstopped v="N" lexicon="yesno-lx" />
    <mpa:biological-medprod-pharmaceutical-legislation v="N" lexicon="yesno-lx" />
    <mpa:antimicrobial v="N" lexicon="yesno-lx" />
    <mpa:reserved-hum v="N" lexicon="yesno-lx" />
  </npl:flags>
  <npl:pharmaceutical-products>
    <npl:pharmaceutical-product id="IDH0XK97NEURIFSRV0">
      <npl:composition>
        <npl:ingredient id="IDH0XK9MNEV2TBSRV0" presentation-substance-name="Y">
          <mpa:ingredient-role-lx v="ACTI" lexicon="ingredient-role-lx" />
          <mpa:quantity-unit-alt-lx v="EQ" lexicon="quantity-unit-alt-lx" />
          <mpa:substance-lx v="ID1QSZMFI1U6F3LCSR" />
        </npl:ingredient>
      </npl:composition>
      <mpa:comp-ref-quantity-lx v="FGE" lexicon="comp-ref-quantity-lx" />
    </npl:pharmaceutical-product>
  </npl:pharmaceutical-products>
  <npl:withdrawal-periods>
    <npl:withdrawal-period comment="En karenstid på 56 dygn skall gälla vid slakt av nöt.&#xD;&#xA;&#xD;&#xA;Mjölk för humankonsumtion får endast tas fr.o.m. 48 timmar efter kalvning. Om kalvning sker före 35 dagar efter behandling får mjölk för humankonsumtion endast tas efter 35 dagar plus 48 timmar efter behandling.">
      <mpa:withdrawal-tissue-lx v="1" lexicon="withdrawal-tissue-lx" />
      <mpa:withdrawal-period v="56" />
      <mpa:withdrawal-period-unit-lx v="DAYS" lexicon="withdrawal-period-unit-lx" />
      <npl:species-of-animals>
        <mpa:species-of-animal-lx v="001" lexicon="species-of-animal-lx" />
      </npl:species-of-animals>
    </npl:withdrawal-period>
    <npl:withdrawal-period comment="56 dygns karenstid skall gälla vid slakt av får som behandlats med Fasinex i en högsta dos av 10 mg triklabendazol/kg kroppsvikt som oral engångsdos.  &#xD;&#xA;&#xD;&#xA;Djur som producerar mjölk för human konsumtion får inte behandlas.">
      <mpa:withdrawal-tissue-lx v="1" lexicon="withdrawal-tissue-lx" />
      <mpa:withdrawal-period v="56" />
      <mpa:withdrawal-period-unit-lx v="DAYS" lexicon="withdrawal-period-unit-lx" />
      <npl:species-of-animals>
        <mpa:species-of-animal-lx v="004" lexicon="species-of-animal-lx" />
      </npl:species-of-animals>
    </npl:withdrawal-period>
  </npl:withdrawal-periods>
  <npl:packages>
    <npl:package>
      <mpa:nplpackid>20140214100036</mpa:nplpackid>
      <mpa:pack-text>
        <mpa:v>Licensförpackning</mpa:v>
      </mpa:pack-text>
      <npl:prescription>
        <mpa:otc v="N" lexicon="yesno-lx" />
      </npl:prescription>
    </npl:package>
  </npl:packages>
</npl:medprod>
